Literature DB >> 24332151

Relation of hypothyroidism and incident atrial fibrillation (from the Framingham Heart Study).

Eun-Jeong Kim1, Asya Lyass2, Na Wang3, Joseph M Massaro2, Caroline S Fox4, Emelia J Benjamin5, Jared W Magnani6.   

Abstract

BACKGROUND: Hyperthyroidism has a well-described association with atrial fibrillation (AF). However, the relation of hypothyroidism to AF has had limited investigation. Hypothyroidism is associated with cardiovascular risk factors, subclinical cardiovascular disease, and overt cardiovascular disease, all of which predispose to AF. We investigated 10-year incidence of AF in a community-dwelling cohort.
METHODS: Among 6,653 Framingham heart Study participants, 5,069 participants, 52% female, with mean age of 57 ± 12 years, were eligible after excluding those with missing thyroid-stimulating hormone (TSH), TSH <0.45 μU/L (hyperthyroid), TSH >19.9 μU/L, or prevalent AF. Thyroid-stimulating hormone was categorized by range (≥0.45 to <4.5, 4.5 to <10.0, 10.0 to ≤19.9 μU/L) and by quartiles. We examined the associations between TSH and 10-year risk of AF using multivariable-adjusted Cox proportional hazards analysis.
RESULTS: Over 10-year follow-up, we observed 277 cases of incident AF. A 1-SD increase in TSH was not associated with increased risk of AF (hazard ratio 1.01, 95% CI 0.90-1.14, P = .83). In categorical analysis, using TSH ≥0.45 to <4.5 μU/L as the referent (equivalent to euthyroid state), we found no significant association between hypothyroidism and 10-year AF risk. Comparing the highest (2.6 < TSH < 19.9 μU/L) to lowest (0.45 < TSH < 1.3 μU/L) quartiles of TSH further did not identify a significant association between TSH levels and 10-year risk of AF.
CONCLUSIONS: In conclusion, we did not identify a significant association between hypothyroidism and 10-year risk of incident AF in a community-based study.
© 2014.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24332151      PMCID: PMC3868014          DOI: 10.1016/j.ahj.2013.10.012

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  28 in total

Review 1.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

2.  Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study.

Authors:  A E Hak; H A Pols; T J Visser; H A Drexhage; A Hofman; J C Witteman
Journal:  Ann Intern Med       Date:  2000-02-15       Impact factor: 25.391

3.  Diabetes mellitus and primary hypothyroidism.

Authors:  K Ganz; G P Kozak
Journal:  Arch Intern Med       Date:  1974-09

4.  Subclinical hyperthyroidism as a risk factor for atrial fibrillation.

Authors:  J Auer; P Scheibner; T Mische; W Langsteger; O Eber; B Eber
Journal:  Am Heart J       Date:  2001-11       Impact factor: 4.749

5.  Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts.

Authors:  Baris Gencer; Tinh-Hai Collet; Vanessa Virgini; Douglas C Bauer; Jacobijn Gussekloo; Anne R Cappola; David Nanchen; Wendy P J den Elzen; Philippe Balmer; Robert N Luben; Massimo Iacoviello; Vincenzo Triggiani; Jacques Cornuz; Anne B Newman; Kay-Tee Khaw; J Wouter Jukema; Rudi G J Westendorp; Eric Vittinghoff; Drahomir Aujesky; Nicolas Rodondi
Journal:  Circulation       Date:  2012-07-19       Impact factor: 29.690

6.  C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation.

Authors:  M K Chung; D O Martin; D Sprecher; O Wazni; A Kanderian; C A Carnes; J A Bauer; P J Tchou; M J Niebauer; A Natale; D R Van Wagoner
Journal:  Circulation       Date:  2001-12-11       Impact factor: 29.690

7.  Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial.

Authors:  Mirjam Christ-Crain; Christian Meier; Merih Guglielmetti; Peter R Huber; Walter Riesen; Jean Jacques Staub; Beat Müller
Journal:  Atherosclerosis       Date:  2003-02       Impact factor: 5.162

8.  Assessment of left ventricular diastolic function by radionuclide ventriculography at rest and exercise in subclinical hypothyroidism, and its response to L-thyroxine therapy.

Authors:  Gabriela Brenta; Luis Alberto Mutti; Marta Schnitman; Osvaldo Fretes; Alberto Perrone; María Luisa Matute
Journal:  Am J Cardiol       Date:  2003-06-01       Impact factor: 2.778

9.  Inflammation as a risk factor for atrial fibrillation.

Authors:  Ronnier J Aviles; David O Martin; Carolyn Apperson-Hansen; Penny L Houghtaling; Pentti Rautaharju; Richard A Kronmal; Russell P Tracy; David R Van Wagoner; Bruce M Psaty; Michael S Lauer; Mina K Chung
Journal:  Circulation       Date:  2003-11-17       Impact factor: 29.690

Review 10.  Subclinical hyperthyroidism and the risk of coronary heart disease and mortality.

Authors:  Tinh-Hai Collet; Jacobijn Gussekloo; Douglas C Bauer; Wendy P J den Elzen; Anne R Cappola; Philippe Balmer; Giorgio Iervasi; Bjørn O Åsvold; José A Sgarbi; Henry Völzke; Bariş Gencer; Rui M B Maciel; Sabrina Molinaro; Alexandra Bremner; Robert N Luben; Patrick Maisonneuve; Jacques Cornuz; Anne B Newman; Kay-Tee Khaw; Rudi G J Westendorp; Jayne A Franklyn; Eric Vittinghoff; John P Walsh; Nicolas Rodondi
Journal:  Arch Intern Med       Date:  2012-05-28
View more
  20 in total

1.  Alterations in atrial ion channels and tissue structure promote atrial fibrillation in hypothyroid rats.

Authors:  Jianqiang Li; Zhaorui Liu; Hongwei Zhao; Fengxiang Yun; Zhaoguang Liang; Dingyu Wang; Xinbo Zhao; Jiawei Zhang; Hai Cang; Yilun Zou; Yue Li
Journal:  Endocrine       Date:  2019-06-07       Impact factor: 3.633

Review 2.  Role of thyroid hormones in ventricular remodeling.

Authors:  Viswanathan Rajagopalan; A Martin Gerdes
Journal:  Curr Heart Fail Rep       Date:  2015-04

Review 3.  European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Authors:  Bulent Gorenek; Antonio Pelliccia; Emelia J Benjamin; Giuseppe Boriani; Harry J Crijns; Richard I Fogel; Isabelle C Van Gelder; Martin Halle; Gulmira Kudaiberdieva; Deirdre A Lane; Torben Bjerregaard Larsen; Gregory Y H Lip; Maja-Lisa Løchen; Francisco Marin; Josef Niebauer; Prashanthan Sanders; Lale Tokgozoglu; Marc A Vos; David R Van Wagoner; Laurent Fauchier; Irina Savelieva; Andreas Goette; Stefan Agewall; Chern-En Chiang; Márcio Figueiredo; Martin Stiles; Timm Dickfeld; Kristen Patton; Massimo Piepoli; Ugo Corra; Pedro Manuel Marques-Vidal; Pompilio Faggiano; Jean-Paul Schmid; Ana Abreu
Journal:  Eur J Prev Cardiol       Date:  2016-11-04       Impact factor: 7.804

Review 4.  European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Authors:  Bulent Gorenek; Antonio Pelliccia; Emelia J Benjamin; Giuseppe Boriani; Harry J Crijns; Richard I Fogel; Isabelle C Van Gelder; Martin Halle; Gulmira Kudaiberdieva; Deirdre A Lane; Torben Bjerregaard Larsen; Gregory Y H Lip; Maja-Lisa Løchen; Francisco Marín; Josef Niebauer; Prashanthan Sanders; Lale Tokgozoglu; Marc A Vos; David R Van Wagoner; Laurent Fauchier; Irina Savelieva; Andreas Goette; Stefan Agewall; Chern-En Chiang; Márcio Figueiredo; Martin Stiles; Timm Dickfeld; Kristen Patton; Massimo Piepoli; Ugo Corra; Pedro Manuel Marques-Vidal; Pompilio Faggiano; Jean-Paul Schmid; Ana Abreu
Journal:  Europace       Date:  2017-02-01       Impact factor: 5.214

Review 5.  [Thyroid gland and the heart : Pathophysiological background, diagnostic and therapeutic consequences].

Authors:  U Dischinger; M Fassnacht
Journal:  Internist (Berl)       Date:  2018-07       Impact factor: 0.743

6.  Prevalence of right atrial non-pulmonary vein triggers in atrial fibrillation patients treated with thyroid hormone replacement therapy.

Authors:  Ki-Hun Kim; Sanghamitra Mohanty; Prasant Mohanty; Chintan Trivedi; Eli Hamilton Morris; Pasquale Santangeli; Rong Bai; Amin Al-Ahmad; John David Burkhardt; Joseph G Gallinghouse; Rodney Horton; Javier E Sanchez; Shane Bailey; Patrick M Hranitzky; Jason Zagrodzky; Soo G Kim; Luigi Di Biase; Andrea Natale
Journal:  J Interv Card Electrophysiol       Date:  2017-03-07       Impact factor: 1.900

Review 7.  Thyroid Function Within the Normal Range, Subclinical Hypothyroidism, and the Risk of Atrial Fibrillation.

Authors:  Christine Baumgartner; Bruno R da Costa; Tinh-Hai Collet; Martin Feller; Carmen Floriani; Douglas C Bauer; Anne R Cappola; Susan R Heckbert; Graziano Ceresini; Jacobijn Gussekloo; Wendy P J den Elzen; Robin P Peeters; Robert Luben; Henry Völzke; Marcus Dörr; John P Walsh; Alexandra Bremner; Massimo Iacoviello; Peter Macfarlane; Jan Heeringa; David J Stott; Rudi G J Westendorp; Kay-Tee Khaw; Jared W Magnani; Drahomir Aujesky; Nicolas Rodondi
Journal:  Circulation       Date:  2017-10-23       Impact factor: 29.690

Review 8.  Hypothyroidism and the Heart.

Authors:  Maja Udovcic; Raul Herrera Pena; Bhargavi Patham; Laila Tabatabai; Abhishek Kansara
Journal:  Methodist Debakey Cardiovasc J       Date:  2017 Apr-Jun

Review 9.  Arrhythmia and thyroid dysfunction.

Authors:  S Marrakchi; F Kanoun; S Idriss; I Kammoun; S Kachboura
Journal:  Herz       Date:  2014-07-04       Impact factor: 1.443

10.  Atrial fibrillation in Mexican population: Differences in presentation, comorbidities and risk factors between men and women

Authors:  Humberto Rodríguez-Reyes; César I Laguna-Muñoz; Carlos F Gallegos-de Luna; Manuel O de-Los-Ríos-Ibarra; José L Salas-Pacheco; José L Leyva-Pons; Luz M Muñoz-Gutiérrez; Arturo Vargas-Hernandez; Karla M Rodríguez-Muñoz; Jaime Barragán-Luna; Marco A Alcocer-Gamba; Jorge Cortez-Lawrenz; Julio Farjat-Ruiz
Journal:  Arch Cardiol Mex       Date:  2022-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.